Breaking News
Investing Pro 0
NEW! Get Actionable Insights with InvestingPro+ Try 7 Days Free
Close

Roche Holding AG (ROz)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
371.0407 +13.0000    +3.59%
12:33:03 - Closed. Currency in CHF ( Disclaimer )
Type:  Equity
Market:  Euro Zone
ISIN:  CH0012032113 
  • Volume: 21,958
  • Bid/Ask: 0.0000 / 0.0000
  • Day's Range: 363.4000 - 375.4000
Roche Holding 371.0407 +13.0000 +3.59%

ROz Technical Analysis

 
A brief summary - strong Buy, Buy, strong Sell, Sell or Neutral signals for the Roche Holding AG stock. A detailed technical analysis through moving averages buy/sell signals (simple and exponential for 5,10,20,50,100 and 200 periods) and common chart indicators (RSI, Stochastics, StochRSI, MACD, ADX, CCI, ROC, Williams %R, Ultimate and more) Buy, Sell, Overbought, Oversold or Neutral signals. Also - pivot points levels for Standard, Fibonacci, Camarilla, Woodie's and Demark's are supplied. All RO Stock Technical Studies are available in different time frames.
Summary:Buy
Moving Averages:NeutralBuy (6)Sell (6)
Technical Indicators:Strong BuyBuy (7)Sell (2)

Pivot PointsSep 27, 2022 04:51PM GMT

Name S3 S2 S1 Pivot Points R1 R2 R3
Classic 355.3816 360.6544 364.8544 370.1272 374.3272 379.6000 383.8000
Fibonacci 360.6544 364.2730 366.5086 370.1272 373.7458 375.9814 379.6000
Camarilla 366.4493 367.3176 368.1859 370.1272 369.9226 370.7910 371.6593
Woodie's 354.8450 360.3861 364.3178 369.8589 373.7906 379.3317 383.2634
DeMark's - - 362.7544 369.0772 372.2272 - -

Technical IndicatorsSep 27, 2022 04:51PM GMT

Name Value Action
RSI(14) 54.013 Neutral
STOCH(9,6) 60.491 Buy
STOCHRSI(14) 76.247 Overbought
MACD(12,26) -0.117 Sell
ADX(14) 29.605 Sell
Williams %R -29.455 Buy
CCI(14) 92.9829 Buy
ATR(14) 3.6907 High Volatility
Highs/Lows(14) 2.7313 Buy
Ultimate Oscillator 58.100 Buy
ROC 2.384 Buy
Bull/Bear Power(13) 2.2851 Buy

Buy: 7

Sell: 2

Neutral: 1


Summary:Strong Buy

Moving AveragesSep 27, 2022 04:51PM GMT

Period Simple Exponential
MA5 370.4590
Buy
370.3422
Buy
MA10 368.8495
Buy
368.7705
Buy
MA20 365.9097
Buy
368.1752
Buy
MA50 371.5030
Sell
372.0078
Sell
MA100 380.4149
Sell
376.1235
Sell
MA200 380.9070
Sell
379.8297
Sell

Buy: 6

Sell: 6


Summary:Neutral

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

RO Comments

Write your thoughts about Roche Holding AG
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Sherlyn Jones
Sherlyn Jones Apr 22, 2021 6:47AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
A large pharmaceutical company, by the name of R. , is pushing down the value of the Spanish company's Pharmamar share price through the funds Consonance Capital and Great Point Partners, so that the biotech company accepts its offer of more than 4500 million dollars.According to this pharma, Pharmamar's products have a great future in oncology and virology, and would be fully engaged in its search for new drugs.
Ruta Rublevska
Ruta Rublevska Nov 16, 2020 3:37AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
13.11.2020. CHMP recommends EU approval of Roche’s Xofluza® (baloxavir marboxil) for the treatment of influenza. This CHMP recommendation brings patients with influenza one step closer to potentially benefiting from Xofluza’s oral one-dose regimen, setting adults and adolescents on the path to feeling better sooner compared to placebo,” said Levi Garraway, M.D., Ph.D., Roche’s Chief Medical Officer and Head of Global Product Development. “We believe that access to effective antivirals for influenza, and particularly their use in the prophylactic setting, could help reduce the strain of the COVID-19 pandemic on healthcare systems in Europe.
Jonny Tr
Jonny Tr May 04, 2020 8:36AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Just like Biolidics. they get approval for Covid19 tests kits in USA
Billy Hanafi
Billy Hanafi Jan 25, 2019 10:12AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
i dont know
edgard hajjar
edgard hajjar May 07, 2018 5:38PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
is the historical price adjusted for stock splits?
Billy Hanafi
Billy Hanafi May 07, 2018 5:38PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
i dont know
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email